{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:07Z","timestamp":1792801447938,"version":"4.5.0"},"reference-count":156,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Parkinson's disease is a chronic and gradually progressive neurodegenerative disorder trig-gered due to the loss of dopamine-releasing neurons in the region of substantia nigra pars compacta characterized by the motor symptoms, such as tremor, bradykinesia, akinesia, and postural instability. Proteinopathies, mitochondrial dysfunction induced dopaminergic neuronal deterioration, and gene mutations are the hallmarks of Parkinson's disease. The bioactive components of Brahmi, such as Bacoside A, Bacoside B, and Bacosaponins, belong to various chemical families. Brahmi's neuropro-tective role includes reducing neuronal oxidative stress, dopaminergic neuronal degeneration, mito-chondrial dysfunction, inflammation, inhibition of \u03b1-synuclein aggregation, and improvement of cog-nitive and learning behaviour. Researchers found that Bacopa monnieri significantly increased brain levels of glutathione, vitamin C, vitamin E, and vitamin A in rats exposed to cigarette smoke. Brahmi has a potent antioxidant property and neuroprotective effects against PD that help reduce oxidative stress and neuroinflammation and enhance dopamine levels. The review collates all the preclinical studies that prove the beneficial neuroprotective effect of Brahmi for treating PD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220316091734","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T11:01:11Z","timestamp":1647514871000},"page":"889-901","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Comprehensive Review on Preclinical Evidence-based Neuroprotective\nPotential of Bacopa monnieri against Parkinson's Disease"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0110-9238","authenticated-orcid":true,"given":"Ahsas","family":"Goyal","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainu","family":"Gopika","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-3926","authenticated-orcid":true,"given":"Debapriya","family":"Garabadu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Health Sciences, Central University of Punjab, Bathinda- 151001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"38","volume":"2","author":"Sandhya S.","year":"2010","unstructured":"Sandhya S.; Vinod K.R.; Sravan K.; Herbs used for brain disorders. Hygeia J D Med 2010,2(1),38-45","journal-title":"Hygeia J D Med"},{"key":"ref=2","first-page":"403","author":"Tripathi K.D.","year":"2001","unstructured":"Tripathi K.D.;  Essentials of medical pharmacology Drugs Used in Mental Illness 2001,403-411","journal-title":"Essentials of medical pharmacology Drugs Used in Mental Illness"},{"key":"ref=3","first-page":"494","author":"Rang H.P.","year":"2006","unstructured":"Rang H.P.; Dale M.M.;  Pharmacology 2006,494-550","journal-title":"Pharmacology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","volume":"71","author":"Beal M.F.","year":"2014","unstructured":"Beal M.F.; Oakes D.; Shoulson I.; A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: No evidence of benefit. JAMA Neurol 2014,71(5),543-552","journal-title":"JAMA Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-013-1005-4","volume":"38","author":"Prakash J.","year":"2013","unstructured":"Prakash J.; Yadav S.K.; Chouhan S.; Singh S.P.; Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochem Res 2013,38(5),972-980","journal-title":"Neurochem Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/1389450121999201013155202","volume":"22","author":"Singla R.K.","year":"2021","unstructured":"Singla R.K.; Agarwal T.; He X.; Shen B.; Herbal resources to combat a progressive","journal-title":"Curr Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","volume":"40","author":"Corona J.C.","year":"2015","unstructured":"Corona J.C.; Duchen M.R.; PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson\u2019s. Neurochem Res 2015,40(2),308-316","journal-title":"Neurochem Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Wang Q.","year":"2015","unstructured":"Wang Q.; Liu Y.; Zhou J.; Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 2015,4,19","journal-title":"Transl Neurodegener"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"Hauser D.N.","year":"2013","unstructured":"Hauser D.N.; Hastings T.G.; Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis 2013,51,35-42","journal-title":"Neurobiol Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"Jiang T.","year":"2016","unstructured":"Jiang T.; Sun Q.; Chen S.; Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 2016,147,1-19","journal-title":"Prog Neurobiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2174\/1570159X14666160104142223","volume":"14","author":"Dadhania V.P.","year":"2016","unstructured":"Dadhania V.P.; Trivedi P.P.; Vikram A.; Tripathi D.N.; Nutraceuticals against neurodegeneration: A mechanistic insight. Curr Neuropharmacol 2016,14(6),627-640","journal-title":"Curr Neuropharmacol"},{"key":"ref=12","first-page":"1","volume":"9923331","author":"Yin R.","year":"2021","unstructured":"Yin R.; Xue J.; Tan Y.; The positive role and mechanism of herbal medicine in Parkinson\u2019s disease. Oxidative Medicine and Cellular Longevity. Article ID 2021,9923331,1-23","journal-title":"Article ID"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.3390\/molecules171011391","volume":"17","author":"Koppula S.","year":"2012","unstructured":"Koppula S.; Kumar H.; More S.V.; Lim H.W.; Hong S.M.; Choi D.K.; Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson\u2019s disease. Molecules 2012,17(10),11391-11420","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.exger.2013.11.012","volume":"50","author":"Van Kampen J.M.","year":"2014","unstructured":"Van Kampen J.M.; Baranowski D.B.; Shaw C.A.; Kay D.G.; Panax ginseng is neuroprotective in a novel progressive model of Parkinson\u2019s disease. Exp Gerontol 2014,50,95-105","journal-title":"Exp Gerontol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1055\/s-0042-107081","volume":"82","author":"R\u00edos J.L.","year":"2016","unstructured":"R\u00edos J.L.; Onteniente M.; Picazo D.; Montesinos M.C.; Medicinal plants and natural products as potential sources for anti Parkinson drugs. Planta Med 2016,82(11-12),942-951","journal-title":"Planta Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1515\/revneuro-2016-0004","volume":"27","author":"Shahpiri Z.","year":"2016","unstructured":"Shahpiri Z.; Bahramsoltani R.; Hosein Farzaei M.; Farzaei F.; Rahimi R.; Phytochemicals as future drugs for Parkinson\u2019s disease: A com-prehensive review. Rev Neurosci 2016,27(6),651-668","journal-title":"Rev Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pbb.2011.01.011","volume":"98","author":"Mu X.","year":"2011","unstructured":"Mu X.; He G.R.; Yuan X.; Li X.X.; Du G.H.; Baicalein protects the brain against neuron impairments induced by MPTP in C57BL\/6 mice. Pharmacol Biochem Behav 2011,98(2),286-291","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ptr.814","volume":"15","author":"Bridi R.","year":"2001","unstructured":"Bridi R.; Crossetti F.P.; Steffen V.M.; Henriques A.T.; The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 2001,15(5),449-451","journal-title":"Phytother Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1007\/s12035-016-9843-0","volume":"54","author":"van der Merwe C.","year":"2017","unstructured":"van der Merwe C.; van Dyk H.C.; Engelbrecht L.; Curcumin rescues a PINK1 knock down SH-SY5Y cellular model of Parkinson\u2019s disease from mitochondrial dysfunction and cell death. Mol Neurobiol 2017,54(4),2752-2762","journal-title":"Mol Neurobiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","volume":"78","author":"Levites Y.","year":"2001","unstructured":"Levites Y.; Weinreb O.; Maor G.; Youdim M.B.H.; Mandel S.; Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001,78(5),1073-1082","journal-title":"J Neurochem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s11064-016-2029-3","volume":"41","author":"Kumar S.","year":"2016","unstructured":"Kumar S.; Mondal A.C.; Neuroprotective, neurotrophic and anti-oxidative role of Bacopamonnieri on CUS induced model of depression in rat. Neurochem Res 2016,41(11),3083-3094","journal-title":"Neurochem Res"},{"key":"ref=22","first-page":"191","volume":"2","author":"Mathur A.","year":"2010","unstructured":"Mathur A.; Verma S.K.; Purohit R.; Pharmacological investigation of Bacopamonnieri on the basis of antioxidant, antimicrobial and anti-inflammatory properties. J Chem Pharm Res 2010,2,191-198","journal-title":"J Chem Pharm Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jep.2009.09.056","volume":"127","author":"Uabundit N.","year":"2010","unstructured":"Uabundit N.; Wattanathorn J.; Mucimapura S.; Ingkaninan K.; Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. J Ethnopharmacol 2010,127(1),26-31","journal-title":"J Ethnopharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/acm.2009.0342","volume":"16","author":"Morgan A.","year":"2010","unstructured":"Morgan A.; Stevens J.; Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med 2010,16(7),753-759","journal-title":"J Altern Complement Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.eujim.2014.05.007","volume":"6","author":"Siddique Y.H.","year":"2014","unstructured":"Siddique Y.H.; Mujtaba S.F.; Faisal M.; Jyoti S.; Naz F.; The effect of Bacopamonnieri leaf extract on dietary supplementation in transgenic Drosophila model of Parkinson\u2019s disease. Eur J Integr Med 2014,6,571-580","journal-title":"Eur J Integr Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbrc.2011.09.010","volume":"413","author":"Jadiya P.","year":"2011","unstructured":"Jadiya P.; Khan A.; Sammi S.R.; Kaur S.; Mir S.S.; Nazir A.; Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson\u2019s disease. Biochem Biophys Res Commun 2011,413(4),605-610","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4306\/pi.2017.14.1.74","volume":"14","author":"Hazra S.","year":"2017","unstructured":"Hazra S.; Kumar S.; Saha G.K.; Mondal A.C.; Reversion of BDNF, Akt and CREB in hippocampus of chronic unpredictable stress induced rats: Effects of phytochemical, Bacopamonnieri. Psychiatry Investig 2017,14(1),74-80","journal-title":"Psychiatry Investig"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4103423","volume":"2016","author":"Kumar N.","year":"2016","unstructured":"Kumar N.; Abichandani L.G.; Thawani V.; Gharpure K.J.; Naidu M.U.R.; Venkat R.G.; Efficacy of standardized extract of Bacopamonnieri (Bacognize1) on cognitive functions of medical students: A six-week, randomized placebo-controlled trial. Evid Based Complement Alternat Med 2016,2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI200317522","volume":"111","author":"Przedborski S.","year":"2003","unstructured":"Przedborski S.; Vila M.; Jackson-Lewis V.; Neurodegeneration: What is it and where are we? J Clin Invest 2003,111(1),3-10","journal-title":"J Clin Invest"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"Jankovic J.","year":"2008","unstructured":"Jankovic J.; Parkinson\u2019s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008,79(4),368-376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1002\/mds.21675","volume":"22","author":"Olanow C.W.","year":"2007","unstructured":"Olanow C.W.; The pathogenesis of cell death in Parkinson\u2019s disease--2007. Mov Disord 2007,22(Suppl. 17),S335-S342","journal-title":"Mov Disord"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-0186(02)00196-1","volume":"43","author":"Shastry B.S.","year":"2003","unstructured":"Shastry B.S.; Neurodegenerative disorders of protein aggregation. Neurochem Int 2003,43(1),1-7","journal-title":"Neurochem Int"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/nrn1434","volume":"10","author":"Andersen J.K.","year":"2004","unstructured":"Andersen J.K.; Oxidative stress in neurodegeneration: Cause or consequence? Nat Med 2004,10(7s)(Suppl.),S18-S25","journal-title":"Nat Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ejmech.2016.08.006","volume":"124","author":"Khanam H.","year":"2016","unstructured":"Khanam H.; Ali A.; Asif M.; Shamsuzzaman. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. Eur J Med Chem 2016,124,1121-1141","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"Walker L.C.","year":"2015","unstructured":"Walker L.C.; Jucker M.; Neurodegenerative diseases: Expanding the prion concept. Annu Rev Neurosci 2015,38,87-103","journal-title":"Annu Rev Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"Selkoe D.J.","year":"2004","unstructured":"Selkoe D.J.; Cell biology of protein misfolding: The examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 2004,6(11),1054-1061","journal-title":"Nat Cell Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"de Lau L.M.L.","year":"2006","unstructured":"de Lau L.M.L.; Breteler M.M.B.; Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006,5(6),525-535","journal-title":"Lancet Neurol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"Van Den Eeden S.K.","year":"2003","unstructured":"Van Den Eeden S.K.; Tanner C.M.; Bernstein A.L.; Incidence of Parkinson\u2019s disease: Variation by age, gender, and race\/ethnicity. Am J Epidemiol 2003,157(11),1015-1022","journal-title":"Am J Epidemiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/01.wnl.0000341769.50075.bb","volume":"72","author":"Driver J.A.","year":"2009","unstructured":"Driver J.A.; Logroscino G.; Gaziano J.M.; Kurth T.; Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 2009,72(5),432-438","journal-title":"Neurology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"Pringsheim T.","year":"2014","unstructured":"Pringsheim T.; Jette N.; Frolkis A.; Steeves T.D.L.; The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis. Mov Disord 2014,29(13),1583-1590","journal-title":"Mov Disord"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"Dorsey E.R.","year":"2007","unstructured":"Dorsey E.R.; Constantinescu R.; Thompson J.P.; Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007,68(5),384-386","journal-title":"Neurology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"Wirdefeldt K.","year":"2011","unstructured":"Wirdefeldt K.; Adami H.O.; Cole P.; Trichopoulos D.; Mandel J.; Epidemiology and etiology of Parkinson\u2019s disease: A review of the evidence. Eur J Epidemiol 2011,26(Suppl. 1),S1-S58","journal-title":"Eur J Epidemiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"Surmeier D.J.","year":"2017","unstructured":"Surmeier D.J.; Obeso J.A.; Halliday G.M.; Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 2017,18(2),101-113","journal-title":"Nat Rev Neurosci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.1249161","volume":"344","author":"Morais V.A.","year":"2014","unstructured":"Morais V.A.; Haddad D.; Craessaerts K.; PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science 2014,344(6180),203-207","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-neuro-062912-114322","volume":"36","author":"Darnell R.B.","year":"2013","unstructured":"Darnell R.B.; RNA protein interaction in neurons. Annu Rev Neurosci 2013,36,243-270","journal-title":"Annu Rev Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0959-4388(97)80007-4","volume":"7","author":"Schultz W.","year":"1997","unstructured":"Schultz W.; Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 1997,7(2),191-197","journal-title":"Curr Opin Neurobiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1097\/00001756-199812210-00020","volume":"9","author":"Hauber W.","year":"1998","unstructured":"Hauber W.; Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats. Neuroreport 1998,9(18),4115-4118","journal-title":"Neuroreport"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","volume":"30","author":"Calabresi P.","year":"2007","unstructured":"Calabresi P.; Picconi B.; Tozzi A.; Di Filippo M.; Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007,30(5),211-219","journal-title":"Trends Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fncir.2013.00152","volume":"7","author":"Baik J.H.","year":"2013","unstructured":"Baik J.H.; Dopamine signaling in reward-related behaviors. Front Neural Circuits a2013,7,152","journal-title":"Front Neural Circuits"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-328X(95)00278-Z","volume":"36","author":"Harrington K.A.","year":"1996","unstructured":"Harrington K.A.; Augood S.J.; Kingsbury A.E.; Foster O.J.; Emson P.C.; Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson\u2019s disease. Brain Res Mol Brain Res 1996,36(1),157-162","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","volume":"20","author":"Miller G.W.","year":"1999","unstructured":"Miller G.W.; Gainetdinov R.R.; Levey A.I.; Caron M.G.; Dopamine transporters and neuronal injury. Trends Pharmacol Sci 1999,20(10),424-429","journal-title":"Trends Pharmacol Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"Luk K.C.","year":"2012","unstructured":"Luk K.C.; Kehm V.; Carroll J.; Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012,338(6109),949-953","journal-title":"Science"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/S0006-3223(00)00812-X","volume":"47","author":"Marsh L.","year":"2000","unstructured":"Marsh L.; Vaughan C.; Schretlen D.; Brandt J.; Mandir A.; Psychomotor aspects of mood disorders in Parkinson\u2019s disease. Biol Psychiatry 2000,47(8),S165","journal-title":"Biol Psychiatry"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.3390\/ijms130810478","volume":"13","author":"Kumar H.","year":"2012","unstructured":"Kumar H.; Lim H.W.; More S.V.; The role of free radicals in the aging brain and Parkinson\u2019s Disease: Convergence and parallelism. Int J Mol Sci 2012,13(8),10478-10504","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1126\/science.6308771","volume":"221","author":"Goldman J.E.","year":"1983","unstructured":"Goldman J.E.; Yen S.H.; Chiu F.C.; Peress N.S.; Lewy bodies of Parkinson\u2019s disease contain neurofilament antigens. Science 1983,221(4615),1082-1084","journal-title":"Science"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","volume":"59","author":"Candy J.M.","year":"1983","unstructured":"Candy J.M.; Perry R.H.; Perry E.K.; Pathological changes in the nucleus of Meynert in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Sci 1983,59(2),277-289","journal-title":"J Neurol Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1159\/000430271","volume":"36","author":"Liu H.","year":"2015","unstructured":"Liu H.; Mao P.; Wang J.; Wang T.; Xie C.H.; Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dys-function via regulating mitochondrial dynamics. Cell Physiol Biochem 2015,36(3),966-979","journal-title":"Cell Physiol Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"Samii A.","year":"2004","unstructured":"Samii A.; Nutt J.G.; Ransom B.R.; Parkinson\u2019s disease. Lancet 2004,363(9423),1783-1793","journal-title":"Lancet"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009282","volume":"2","author":"Mazzoni P.","year":"2012","unstructured":"Mazzoni P.; Shabbott B.; Cort\u00e9s J.C.; Motor control abnormalities in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2012,2(6)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1590\/0004-282X20160126","volume":"74","author":"Teive H.A.","year":"2016","unstructured":"Teive H.A.; Bertucci D.C.; Munhoz R.P.; Unusual motor and non-motor symptoms and signs in the early stage of Parkinson\u2019s disease. Arq Neuropsiquiatr 2016,74(10),781-784","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/mds.23829","volume":"26","author":"Fox S.H.","year":"2011","unstructured":"Fox S.H.; Katzenschlager R.; Lim S.Y.; The movement disorder society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 2011,26(Suppl. 3),S2-S41","journal-title":"Mov Disord"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"Connolly B.S.","year":"2014","unstructured":"Connolly B.S.; Lang A.E.; Pharmacological treatment of Parkinson disease: A review. JAMA 2014,311(16),1670-1683","journal-title":"JAMA"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1242\/dmm.007575","volume":"4","author":"Barone M.C.","year":"2011","unstructured":"Barone M.C.; Sykiotis G.P.; Bohmann D.; Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson\u2019s disease. Dis Model Mech 2011,4(5),701-707","journal-title":"Dis Model Mech"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1389200217666160709204826","volume":"18","author":"Solayman M.","year":"2017","unstructured":"Solayman M.; Islam M.A.; Alam F.; Khalil M.I.; Kamal M.A.; Gan S.H.; Natural products combating neurodegeneration: Parkinson\u2019s disease. Curr Drug Metab 2017,18(1),50-61","journal-title":"Curr Drug Metab"},{"key":"ref=65","author":"Subramanian T.","unstructured":"Subramanian T.; 32nd annual meeting for society for neurosciences. , 2002; abstract No. 787.4"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12640-009-9011-7","volume":"15","author":"Kasture S.","year":"2009","unstructured":"Kasture S.; Pontis S.; Pinna A.; Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson\u2019s disease. Neurotox Res 2009,15(2),111-122","journal-title":"Neurotox Res"},{"key":"ref=67","first-page":"10","author":"Brown J.H.","year":"2001","unstructured":"Brown J.H.; Taylor P.; Goodman and Gilman\u2019s the pharmacological basis of therapeutics. Muscarinic Receptors Agonists and Antagonists 2001,10","journal-title":"Muscarinic Receptors Agonists and Antagonists"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.disamonth.2007.05.002","volume":"53","author":"Rezak M.","year":"2007","unstructured":"Rezak M.; Current pharmacotherapeutic treatment options in Parkinson\u2019s disease. Dis Mon 2007,53(4),214-222","journal-title":"Dis Mon"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1191\/0960327105ht509oa","volume":"24","author":"Ahmad M.","year":"2005","unstructured":"Ahmad M.; Saleem S.; Ahmad A.S.; Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 2005,24(3),137-147","journal-title":"Hum Exp Toxicol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jep.2005.01.008","volume":"98","author":"Franco C.I.","year":"2005","unstructured":"Franco C.I.; Morais L.C.; Quintans-J\u00fanior L.J.; Almeida R.N.; Antoniolli A.R.; CNS pharmacological effects of the hydroalcoholic extract of Sida cordifolia L. leaves. J Ethnopharmacol 2005,98(3),275-279","journal-title":"J Ethnopharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuro.2013.08.005","volume":"39","author":"Khurana N.","year":"2013","unstructured":"Khurana N.; Gajbhiye A.; Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson\u2019s disease. Neurotoxicology 2013,39,57-64","journal-title":"Neurotoxicology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pbb.2006.01.005","volume":"83","author":"Ahmad M.","year":"2006","unstructured":"Ahmad M.; Yousuf S.; Khan M.B.; Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: Behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 2006,83(1),150-160","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2131\/jts.35.41","volume":"35","author":"Haleagrahara N.","year":"2010","unstructured":"Haleagrahara N.; Ponnusamy K.; Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats. J Toxicol Sci 2010,35(1),41-47","journal-title":"J Toxicol Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/0253-7613.129312","volume":"46","author":"Kosaraju J.","year":"2014","unstructured":"Kosaraju J.; Chinni S.; Roy P.D.; Kannan E.; Antony A.S.; Kumar M.N.; Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Indian J Pharmacol 2014,46(2),176-180","journal-title":"Indian J Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0973-7847.99949","volume":"6","author":"Kulkarni R.","year":"2012","unstructured":"Kulkarni R.; Girish K.J.; Kumar A.; Nootropic herbs (MedhyaRasayana) in Ayurveda: An update. Pharmacogn Rev 2012,6(12),147-153","journal-title":"Pharmacogn Rev"},{"key":"ref=76","first-page":"400","volume":"1","author":"Dutta T.","year":"1963","unstructured":"Dutta T.; Basu U.P.; Terpenoids: Part II-Isolation of new triterpenesaponin, monnierin, from Bacopamonniera Wettst. Indian J Chem 1963,1,400-408","journal-title":"Indian J Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctim.2019.03.016","volume":"44","author":"Sukumaran N.P.","year":"2019","unstructured":"Sukumaran N.P.; Amalraj A.; Gopi S.; Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst - A review on its mechanistic aspects. Complement Ther Med 2019,44,68-82","journal-title":"Complement Ther Med"},{"key":"ref=78","first-page":"84","volume":"5","author":"Basu N.","year":"1967","unstructured":"Basu N.; Rastogi R.; Dhar M.L.; Chemical examination of bacopamiennierawettst: Part iii-bacoside b. Indian J Chem 1967,5,84-95","journal-title":"Indian J Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s11033-021-06236-w","volume":"48","author":"Shalini V.T.","year":"2021","unstructured":"Shalini V.T.; Neelakanta S.J.; Sriranjini J.S.; Neuroprotection with Bacopa monnieri-A review of experimental evidence. Mol Biol Rep 2021,48(3),2653-2668","journal-title":"Mol Biol Rep"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/B978-1-4160-4836-7.00002-X","author":"Zhang J.M.","year":"2009","unstructured":"Zhang J.M.; Mark L.B.;  Pathophysiology of pain Current Therapy in Pain 2009,4-8","journal-title":"Pathophysiology of pain Current Therapy in Pain"},{"key":"ref=81","first-page":"227","author":"Surajit C.","year":"2017","unstructured":"Surajit C.; Rajasri B.; Dibyajyoti B.;  Infections: A possible risk factor for type 2 diabetes Advances in Clinical Chemistry 2017,227-251","journal-title":"Infections: A possible risk factor for type 2 diabetes Advances in Clinical Chemistry"},{"key":"ref=82","first-page":"1051","author":"Dejan M.","year":"2011","unstructured":"Dejan M.; Snjezana Z.M.; Rich M.B.; Michael A.; Thomas J.M.;  Neuroinflammation and oxidative injury in developmental neurotoxicity Reproductive and Developmental Toxicology 2011,1051-1061","journal-title":"Neuroinflammation and oxidative injury in developmental neurotoxicity Reproductive and Developmental Toxicology"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2015.06.010","volume":"154","author":"Nakagawa Y.","year":"2015","unstructured":"Nakagawa Y.; Chiba K.; Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther 2015,154,21-35","journal-title":"Pharmacol Ther"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","volume":"274","author":"Gonz\u00e1lez H.","year":"2014","unstructured":"Gonz\u00e1lez H.; Elgueta D.; Montoya A.; Pacheco R.; Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J Neuroimmunol 2014,274(1-2),1-13","journal-title":"J Neuroimmunol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.dcn.2014.07.001","volume":"11","author":"Ganguly P.","year":"2015","unstructured":"Ganguly P.; Brenhouse H.C.; Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity. Dev Cogn Neurosci 2015,11,18-30","journal-title":"Dev Cogn Neurosci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"Heneka M.T.","year":"2014","unstructured":"Heneka M.T.; Kummer M.P.; Latz E.; Innate immune activation in neurodegenerative disease. Nat Rev Immunol 2014,14(7),463-477","journal-title":"Nat Rev Immunol"},{"key":"ref=87","first-page":"219","author":"Lurie D.I.","year":"2015","unstructured":"Lurie D.I.; Coffin J.;  The role of Bacopa monnieri in inflammatory and neu-rodegenerative diseases Occurrences, structure, bio-synthesis, and health benefits based on their evidences of medicinal phyto-chemicals in vegetables and fruits 2015,219-238","journal-title":"The role of Bacopa monnieri in inflammatory and neu-rodegenerative diseases Occurrences, structure, bio-synthesis, and health benefits based on their evidences of medicinal phyto-chemicals in vegetables and fruits"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10787-010-0046-4","volume":"19","author":"Viji V.","year":"2011","unstructured":"Viji V.; Helen A.; Inhibition of pro-inflammatory mediators: Role of Bacopa monniera (L.) Wettst. Inflammopharmacology 2011,19(5),283-291","journal-title":"Inflammopharmacology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.intimp.2010.04.013","volume":"10","author":"Viji V.","year":"2010","unstructured":"Viji V.; Shobha B.; Kavitha S.K.; Ratheesh M.; Kripa K.; Helen A.; Betulinic acid isolated from Bacopa monniera (L.) Wettst suppresses lipopolysaccharide stimulated interleukin-6 production through modulation of nuclear factor-kappaB in peripheral blood mononuclear cells. Int Immunopharmacol 2010,10(8),843-849","journal-title":"Int Immunopharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1039\/C3FO60467E","volume":"5","author":"Williams R.","year":"2014","unstructured":"Williams R.; M\u00fcnch G.; Gyengesi E.; Bennett L.; Bacopa monnieri (L.) exerts anti-inflammatory effects on cells of the innate immune system in vitro. Food Funct 2014,5(3),517-520","journal-title":"Food Funct"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0973-8258.62156","volume":"4","author":"Gohil K.J.","year":"2010","unstructured":"Gohil K.J.; Patel J.A.; A review on Bacopamonniera: Current research and future prospects. Int J Green Pharm 2010,4,1-9","journal-title":"Int J Green Pharm"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0893-133X(01)00419-5","volume":"27","author":"Roodenrys S.","year":"2002","unstructured":"Roodenrys S.; Booth D.; Bulzomi S.; Phipps A.; Micallef C.; Smoker J.; Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002,27(2),279-281","journal-title":"Neuropsychopharmacology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.phymed.2003.12.008","volume":"12","author":"Russo A.","year":"2005","unstructured":"Russo A.; Borrelli F.; Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine 2005,12(4),305-317","journal-title":"Phytomedicine"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/978-3-642-22144-6_157","author":"Majumdar S.","year":"2013","unstructured":"Majumdar S.; Basu A.; Paul P.; Halder M.; Jha S.;  Bacosides and neuroprotection Natural products 2013,3639-3660","journal-title":"Bacosides and neuroprotection Natural products"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/rej.2013.1431","volume":"16","author":"Aguiar S.","year":"2013","unstructured":"Aguiar S.; Borowski T.; Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res 2013,16(4),313-326","journal-title":"Rejuvenation Res"},{"key":"ref=96","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/945217","volume":"2015","author":"Rajan K.E.","year":"2015","unstructured":"Rajan K.E.; Preethi J.; Singh H.K.; Molecular and functional characterization of Bacopamonniera: A retrospective review. Evid Based Complement Alternat Med 2015,2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=97","doi-asserted-by":"publisher","DOI":"10.1086\/402350","volume":"33","author":"Chopra R.N.","year":"1958","unstructured":"Chopra R.N.; Nayar S.L.; Chopra I.C.; Glossary of Indian medicinal plants. Quarter Rev Biol 1958,33(2)","journal-title":"Quarter Rev Biol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1248\/cpb.54.907","volume":"54","author":"Murthy P.B.","year":"2006","unstructured":"Murthy P.B.; Raju V.R.; Ramakrisana T.; Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull (Tokyo) 2006,54(6),907-911","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=99","first-page":"212","volume":"1","author":"Chatterji N.","year":"1963","unstructured":"Chatterji N.; Rastogi R.P.; Dhar M.L.; Chemical examination of Bacopa monniera Wettst.: Part I-Isolation of chemical constituents. Indian J Chem 1963,1,212-215","journal-title":"Indian J Chem"},{"key":"ref=100","first-page":"189","author":"Singh H.","year":"1992","unstructured":"Singh H.; Dhawan B.N.;  Drugs affecting learning and memory 1992,189","journal-title":"Drugs affecting learning and memory"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/pca.805","volume":"16","author":"Deepak M.","year":"2005","unstructured":"Deepak M.; Sangli G.K.; Arun P.C.; Amit A.; Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal 2005,16(1),24-29","journal-title":"Phytochem Anal"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.phytochem.2005.09.016","volume":"66","author":"Sivaramakrishna C.","year":"2005","unstructured":"Sivaramakrishna C.; Rao C.V.; Trimurtulu G.; Vanisree M.; Subbaraju G.V.; Triterpenoid glycosides from Bacopa monnieri. Phytochemistry 2005,66(23),2719-2728","journal-title":"Phytochemistry"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/pca.2347","volume":"23","author":"Srivastava P.","year":"2012","unstructured":"Srivastava P.; Raut H.N.; Puntambekar H.M.; Desai A.C.; Stability studies of crude plant material of Bacopa monnieri and quantitative determination of bacopaside I and bacoside A by HPLC. Phytochem Anal 2012,23(5),502-507","journal-title":"Phytochem Anal"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fitote.2013.03.011","volume":"87","author":"Deepak M.","year":"2013","unstructured":"Deepak M.; Amit A.; \u2018Bacoside B\u2019--the need remains for establishing identity. Fitoterapia 2013,87,7-10","journal-title":"Fitoterapia"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/ptr.5116","volume":"28","author":"Singh R.","year":"2014","unstructured":"Singh R.; Ramakrishna R.; Bhateria M.; Bhatta R.S.; In vitro evaluation of Bacopa monniera extract and individual constituents on human recombinant monoamine oxidase enzymes. Phytother Res 2014,28(9),1419-1422","journal-title":"Phytother Res"},{"key":"ref=106","first-page":"1028","volume":"20","author":"Rauf K.","year":"2013","unstructured":"Rauf K.; Subhan F.; Al-Othman A.M.; Khan I.; Zarrelli A.; Shah M.R.; Preclinical profile of bacopasides from Bacopa monnieri (BM) as an emerging class of therapeutics for management of chronic pains. Curr Med Chem 2013,20(8),1028-1037","journal-title":"Curr Med Chem"},{"key":"ref=107","first-page":"24","volume":"3","author":"Chatterji N.","year":"1965","unstructured":"Chatterji N.; Rastogi R.P.; Dhar M.L.; Chemical examination of Bacopamonniera Wettst: Part I-isolation of chemical constituents. Indian J Chem 1965,3,24-29","journal-title":"Indian J Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0031-9422(95)00936-1","volume":"42","author":"Garai S.","year":"1996","unstructured":"Garai S.; Mahato S.B.; Ohtani K.; Yamasaki K.; Dammarane-type triterpenoid saponins from Bacopa monniera. Phytochemistry 1996,42(3),815-820","journal-title":"Phytochemistry"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0031-9422(01)00275-8","volume":"58","author":"Chakravarty A.K.","year":"2001","unstructured":"Chakravarty A.K.; Sarkar T.; Masuda K.; Shiojima K.; Nakane T.; Kawahara N.; Bacopaside I and II: Two pseudojujubogenin glycosides from Bacopa monniera. Phytochemistry 2001,58(4),553-556","journal-title":"Phytochemistry"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1248\/cpb.50.1616","volume":"50","author":"Chakravarty A.K.","year":"2002","unstructured":"Chakravarty A.K.; Sarkar T.; Nakane T.; Kawahara N.; Masuda K.; New phenylethanoid glycosides from Bacopa monniera. Chem Pharm Bull (Tokyo) 2002,50(12),1616-1618","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1248\/cpb.51.215","volume":"51","author":"Chakravarty A.K.","year":"2003","unstructured":"Chakravarty A.K.; Garai S.; Masuda K.; Nakane T.; Kawahara N.; Bacopasides III-V: Three new triterpenoid glycosides from Bacopa monniera. Chem Pharm Bull (Tokyo) 2003,51(2),215-217","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.phytochem.2007.03.013","volume":"68","author":"Bhandari P.","year":"2007","unstructured":"Bhandari P.; Kumar N.; Singh B.; Kaul V.K.; Cucurbitacins from Bacopa monnieri. Phytochemistry 2007,68(9),1248-1254","journal-title":"Phytochemistry"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.arplant.55.031903.141701","volume":"55","author":"Apel K.","year":"2004","unstructured":"Apel K.; Hirt H.; Reactive oxygen species: Metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 2004,55,373-399","journal-title":"Annu Rev Plant Biol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm.3625","volume":"20","author":"Kawagishi H.","year":"2014","unstructured":"Kawagishi H.; Finkel T.; Unraveling the truth about antioxidants: ROS and disease: Finding the right balance. Nat Med 2014,20(7),711-713","journal-title":"Nat Med"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0197-4580(02)00019-2","volume":"23","author":"Floyd R.A.","year":"2002","unstructured":"Floyd R.A.; Hensley K.; Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002,23(5),795-807","journal-title":"Neurobiol Aging"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jnutbio.2013.01.002","volume":"24","author":"Parletta N.","year":"2013","unstructured":"Parletta N.; Milte C.M.; Meyer B.J.; Nutritional modulation of cognitive function and mental health. J Nutr Biochem 2013,24(5),725-743","journal-title":"J Nutr Biochem"},{"key":"ref=117","first-page":"451","volume":"13","author":"Jenny N.S.","year":"2012","unstructured":"Jenny N.S.; Inflammation in aging: Cause, effect, or both? Discov Med 2012,13(73),451-460","journal-title":"Discov Med"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1152\/ajpregu.00327.2006","volume":"292","author":"Kregel K.C.","year":"2007","unstructured":"Kregel K.C.; Zhang H.J.; An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007,292(1),R18-R36","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=119","author":"De Grey A.","year":"1999","unstructured":"De Grey A.;  The mitochondrial free radical theory of aging 1999","journal-title":"The mitochondrial free radical theory of aging"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/00003495-199549030-00003","volume":"49","author":"Maxwell S.R.J.","year":"1995","unstructured":"Maxwell S.R.J.; Prospects for the use of antioxidant therapies. Drugs 1995,49(3),345-361","journal-title":"Drugs"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"Magistretti P.J.","year":"2015","unstructured":"Magistretti P.J.; Allaman I.; A cellular perspective on brain energy metabolism and functional imaging. Neuron 2015,86(4),883-901","journal-title":"Neuron"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0531-5565(02)00015-3","volume":"37","author":"Arivazhagan P.","year":"2002","unstructured":"Arivazhagan P.; Shila S.; Kumaran S.; Panneerselvam C.; Effect of DL-a lipoic acid in various brain regions of aged rats. Exp Gerontol 2002,37,803-811","journal-title":"Exp Gerontol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"Valko M.","year":"2007","unstructured":"Valko M.; Leibfritz D.; Moncol J.; Cronin M.T.; Mazur M.; Telser J.; Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007,39(1),44-84","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1360-1385(97)01018-2","volume":"2","author":"Rice-Evans C.","year":"1997","unstructured":"Rice-Evans C.; Miller N.; Paganga G.; Antioxidant properties of phenolic compounds. Trends Plant Sci 1997,2,152-159","journal-title":"Trends Plant Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/002215540305100606","volume":"51","author":"Schad A.","year":"2003","unstructured":"Schad A.; Fahimi H.D.; V\u00f6lkl A.; Baumgart E.; Expression of catalase mRNA and protein in adult rat brain: Detection by nonradioactive in situ hybridization with signal amplification by catalyzed reporter deposition (ISH-CARD) and immunohistochemistry (IHC)\/immunofluorescence (IF). J Histochem Cytochem 2003,51(6),751-760","journal-title":"J Histochem Cytochem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/10799893.2012.672994","volume":"32","author":"Naz\u0131ro\u011flu M.","year":"2012","unstructured":"Naz\u0131ro\u011flu M.; Molecular role of catalase on oxidative stress-induced Ca(2+) signaling and TRP cation channel activation in nervous system. J Recept Sig Transd 2012,32(3),134-141","journal-title":"J Recept Sig Transd"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11064-011-0681-1","volume":"37","author":"Rastogi M.","year":"2012","unstructured":"Rastogi M.; Ojha R.P.; Devi B.P.; Aggarwal A.; Agrawal A.; Dubey G.P.; Amelioration of age associated neuroinflammation on long term baco-sides treatment. Neurochem Res 2012,37(4),869-874","journal-title":"Neurochem Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.etap.2008.08.007","volume":"27","author":"Kapoor R.","year":"2009","unstructured":"Kapoor R.; Srivastava S.; Kakkar P.; Bacopa monnieri modulates antioxidant responses in brain and kidney of diabetic rats. Environ Toxicol Pharmacol 2009,27(1),62-69","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/acschemneuro.6b00438","volume":"8","author":"Malishev R.","year":"2017","unstructured":"Malishev R.; Shaham-Niv S.; Nandi S.; Kolusheva S.; Gazit E.; Jelinek R.; Bacoside-A, an Indian traditional-medicine substance, inhibits \u03b2-amyloid cytotoxicity, fibrillation, and membrane interactions. ACS Chem Neurosci 2017,8(4),884-891","journal-title":"ACS Chem Neurosci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","volume":"1842","author":"Gan L.","year":"2014","unstructured":"Gan L.; Johnson J.A.; Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta 2014,1842(8),1208-1218","journal-title":"Biochim Biophys Acta"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/pin.12261","volume":"65","author":"Yamazaki H.","year":"2015","unstructured":"Yamazaki H.; Tanji K.; Wakabayashi K.; Matsuura S.; Itoh K.; Role of the Keap1\/Nrf2 pathway in neurodegenerative diseases. Pathol Int 2015,65(5),210-219","journal-title":"Pathol Int"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neuro.2009.08.012","volume":"30","author":"Hosamani R.","year":"2009","unstructured":"Hosamani R.; Muralidhara. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster. Neurotoxicology 2009,30(6),977-985","journal-title":"Neurotoxicology"},{"key":"ref=133","first-page":"758","volume":"54","author":"Singh B.","year":"2016","unstructured":"Singh B.; Pandey S.; Verma R.; Ansari J.A.; Mahdi A.A.; Comparative evaluation of extract of Bacopamonnieri and Mucunapruriens as neuroprotectant in MPTP model of Parkinson\u2019s disease. Indian J Exp Biol 2016,54,758-766","journal-title":"Indian J Exp Biol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.lfs.2005.07.030","volume":"78","author":"Anbarasi K.","year":"2006","unstructured":"Anbarasi K.; Vani G.; Balakrishna K.; Devi C.S.; Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci 2006,78(12),1378-1384","journal-title":"Life Sci"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jbt.20050","volume":"19","author":"Anbarasi K.","year":"2005","unstructured":"Anbarasi K.; Vani G.; Balakrishna K.; Devi C.S.; Effect of bacoside A on membrane-bound ATPases in the brain of rats exposed to cigarette smoke. J Biochem Mol Toxicol 2005,19(1),59-65","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1179\/1476830514Y.0000000149","volume":"19","author":"Hosamani R.","year":"2016","unstructured":"Hosamani R.; Krishna G.; Muralidhara. Standardized Bacopa monnieri extract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain. Nutr Neurosci 2016,19(10),434-446","journal-title":"Nutr Neurosci"},{"key":"ref=137","first-page":"75","volume":"47","author":"Hosamani R.","year":"2010","unstructured":"Hosamani R.; Muralidhara. Prophylactic treatment with Bacopa monnieri leaf powder mitigates paraquat-induced oxidative perturbations and lethality in Drosophila melanogaster. Indian J Biochem Biophys 2010,47(2),75-82","journal-title":"Indian J Biochem Biophys"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10571-011-9776-0","volume":"32","author":"Shinomol G.K.","year":"2012","unstructured":"Shinomol G.K.; Mythri R.B.; Srinivas Bharath M.M.; Muralidhara. Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain. Cell Mol Neurobiol 2012,32(3),455-465","journal-title":"Cell Mol Neurobiol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnana.2015.00032","volume":"9","author":"Herrero M.T.","year":"2015","unstructured":"Herrero M.T.; Estrada C.; Maatouk L.; Vyas S.; Inflammation in Parkinson\u2019s disease: Role of glucocorticoids. Front Neuroanat 2015,9,32","journal-title":"Front Neuroanat"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jep.2016.07.073","volume":"197","author":"Nemetchek M.D.","year":"2017","unstructured":"Nemetchek M.D.; Stierle A.A.; Stierle D.B.; Lurie D.I.; The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol 2017,197,92-100","journal-title":"J Ethnopharmacol"},{"key":"ref=141","first-page":"633","volume":"32","author":"Jain P.","year":"1994","unstructured":"Jain P.; Khanna N.K.; Trehan N.; Pendse V.K.; Godhwani J.L.; Antiinflammatory effects of an Ayurvedic preparation, Brahmi Rasayan, in rodents. Indian J Exp Biol 1994,32(9),633-636","journal-title":"Indian J Exp Biol"},{"key":"ref=142","first-page":"1","author":"Hans O","year":"2012","unstructured":"Hans O; David HB;  1\u2013Introduction to mechanisms of allergic disease Allergy 2012,1-32","journal-title":"1\u2013Introduction to mechanisms of allergic disease Allergy"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-12-385493-3.00007-3","volume":"103","author":"Cho S.","year":"2011","unstructured":"Cho S.; Hwang E.S.; Fluorescence-based detection and quantification of features of cellular senescence. Methods Cell Biol 2011,103,149-188","journal-title":"Methods Cell Biol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0166-2236(93)90143-A","volume":"16","author":"Sawle G.V.","year":"1993","unstructured":"Sawle G.V.; Myers R.; The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci 1993,16(5),172-176","journal-title":"Trends Neurosci"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/WNL.55.1.7","volume":"55","author":"Obeso J.A.","year":"2000","unstructured":"Obeso J.A.; Rodriguez-Oroz M.C.; Rodriguez M.; Pathophysiologic basis of surgery for Parkinson\u2019s disease. Neurology 2000,55(12)(Suppl. 6),S7-S12","journal-title":"Neurology"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.10332","volume":"18","author":"Teismann P.","year":"2003","unstructured":"Teismann P.; Tieu K.; Cohen O.; Pathogenic role of glial cells in Parkinson\u2019s disease. Mov Disord 2003,18(2),121-129","journal-title":"Mov Disord"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","author":"Sawada M.","year":"2006","unstructured":"Sawada M.; Imamura K.; Nagatsu T.; Role of cytokines in inflammatory process in Parkinson\u2019s disease. J Neural Transm Suppl 2006(70),373-381","journal-title":"J Neural Transm Suppl"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"Blum D.","year":"2001","unstructured":"Blum D.; Torch S.; Lambeng N.; Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol 2001,65(2),135-172","journal-title":"Prog Neurobiol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/brain\/awn323","volume":"132","author":"Simunovic F.","year":"2009","unstructured":"Simunovic F.; Yi M.; Wang Y.; Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson\u2019s disease pathology. Brain 2009,132(Pt 7),1795-1809","journal-title":"Brain"},{"key":"ref=150","first-page":"12","volume":"1","author":"Pandey S.","year":"2013","unstructured":"Pandey S.; Singh B.; Mahdi A.A.; Therapeutic potential of noo-tropic Bacopamonnieri in prevention","journal-title":"Int J Scientific Innov Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainresbull.2017.10.007","volume":"135","author":"Singh B.","year":"2017","unstructured":"Singh B.; Pandey S.; Yadav S.K.; Verma R.; Singh S.P.; Mahdi A.A.; Role of ethanolic extract of Bacopa monnieri against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mice model via inhibition of apoptotic pathways of dopaminergic neurons. Brain Res Bull 2017,135,120-128","journal-title":"Brain Res Bull"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pathophys.2018.03.002","volume":"25","year":"2018","unstructured":"Anand T, Khanum F. Attenuation of cytotoxicity induced by tBHP in H9C2 cells by Bacopa monniera and Bacoside A. Pathophysiology T MM2018,25(2),143-149","journal-title":"Pathophysiology"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","volume":"60","author":"Chung Y.C.","year":"2011","unstructured":"Chung Y.C.; Kim S.R.; Park J.Y.; Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 2011,60(6),963-974","journal-title":"Neuropharmacology"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000475900","volume":"24","author":"Chaudhari K.S.","year":"2017","unstructured":"Chaudhari K.S.; Tiwari N.R.; Tiwari R.R.; Sharma R.S.; Neurocognitive effect of nootropic drug Brahmi (Bacopamonnieri) in Alzheimer\u2019s disease. Ann Neurosci 2017,24(2),111-122","journal-title":"Ann Neurosci"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-4632.2008.03475.x","volume":"47","author":"Khandpur S.","year":"2008","unstructured":"Khandpur S.; Malhotra A.K.; Bhatia V.; Chronic arsenic toxicity from Ayurvedic medicines. Int J Dermatol 2008,47(6),618-621","journal-title":"Int J Dermatol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.envint.2017.08.005","volume":"108","author":"Bolan S.","year":"2017","unstructured":"Bolan S.; Kunhikrishnan A.; Seshadri B.; Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines. Environ Int 2017,108,103-118","journal-title":"Environ Int"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220316091734","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202266\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220316091734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T14:29:58Z","timestamp":1660660198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202266\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":156,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220316091734","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}